LakeShore Biopharma Co Net Tangible Assets

LakeShore Biopharma Co (YS) currently reports a net tangible assets of $500M as of March 2025. That compares with $590M in the prior-year period — down 14.6% year over year. Use the charts on this page to explore LakeShore Biopharma Co's net tangible assets history and peer comparisons.

LakeShore Biopharma Co's net tangible assets decreased from $590M to $500M — a 14.6% year-over-year decrease (period ending March 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

LakeShore Biopharma Co reported $500M in net tangible assets as of March 2025. That compares with $590M in the prior-year period — down 14.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $500M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for LakeShore Biopharma Co, and consider following YS for alerts when major investors trade the stock.